| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |